Last reviewed · How we verify

NCT06518473

Atopy and Frequency of Exacerbation in Chronic Obstructive Pulmonary Disease Patients

Recruiting now Last updated 3 August 2025
What this trial tests

trial testing Skin prick test in Chronic Obstructive Pulmonary Disease in 50 participants. Currently enrolling.

Timeline
14 July 2024
Primary endpoint
15 September 2025
15 December 2025

Quick facts

Lead sponsorMansoura University Hospital
StatusRecruiting now
Study typeOBSERVATIONAL
Enrollment50
Start date14 July 2024
Primary completion15 September 2025
Estimated completion15 December 2025
Sites1 location across Egypt

Drugs / interventions tested

Conditions studied

Sponsor

Mansoura University Hospital

Who can join

Adults 40 to 70, any sex, with Chronic Obstructive Pulmonary Disease. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Chronic Obstructive Pulmonary Disease (COPD) is a heterogeneous lung condition characterized by chronic respiratory symptoms (dyspnea, cough, sputum production and/or exacerbations) due to abnormalities of airways (bronchitis, bronchiolitis) and/or alveoli (emphysema) that cause persistent, often progressive, airflow obstruction. The presence of non-fully reversible airflow obstruction (FEV1/FVC \< 0.7 post-bronchodilation) measured by spirometry confirms the diagnosis of COPD

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other trials of Skin prick test

Trials testing the same drug.

Other recruiting trials for Chronic Obstructive Pulmonary Disease

Currently open trials in the same condition.

Other Mansoura University Hospital trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06518473.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing